PharmaShots Interview: Kathy Davy, VP of Oncology at Thermo Fisher Scientific Shares Insights on the Real-World Data from Patients with NSCLC at ASCO 2022

Shots:Kathy spoke about the major outcomes from the real-world evidence data presented at the ASCO 2022Kathy also emphasized on how next-generation sequencing can improve genomic testingThe interview gives a view of Thermo Fisher’s vision to bring targeted sequencing that provides faster results for cliniciansSmriti: Tell us in detail about the key…